Cargando…

Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study

BACKGROUND: A ready-to-use liquid formulation of abobotulinumtoxinA (aboBoNT-A solution) has been developed. OBJECTIVES: The aim of this study was to assess the long-term efficacy and safety of aboBoNT-A solution for the treatment of glabellar lines. METHODS: This was a multicenter, multinational, P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kestemont, Philippe, Hilton, Said, Andriopoulos, Bill, Prygova, Inna, Thompson, Catherine, Volteau, Magali, Ascher, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Cosmetic Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844979/ https://www.ncbi.nlm.nih.gov/pubmed/34472596 http://dx.doi.org/10.1093/asj/sjab329

Ejemplares similares

Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
por: Hilton, Said, et al.
Publicado: (2022)

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
por: Ascher, Benjamin, et al.
Publicado: (2019)

Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
por: Ascher, Benjamin, et al.
Publicado: (2021)

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial
por: Ascher, Benjamin, et al.
Publicado: (2020)

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2022)

Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2023)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport(®)/Azzalure(®)): Primary Results of the APPEAL Noninterventional Study
por: Gubanova, Elena, et al.
Publicado: (2018)

Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review
por: Galadari, Hassan, et al.
Publicado: (2021)

AbobotulinumtoxinA in the Management of Hallux Valgus in Adult Patients: Results of a Randomised And Placebo-Controlled Phase 2 Trial
por: Silva, Robert, et al.
Publicado: (2020)

A Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines
por: Schlessinger, Joel, et al.
Publicado: (2021)

Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler
por: Cartier, Hugues, et al.
Publicado: (2020)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data
por: Solish, Nowell, et al.
Publicado: (2022)

The Crest Injection Technique for Glabellar Line Correction and the Paracentral Artery
por: Tansatit, Tanvaa, et al.
Publicado: (2021)

A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines
por: Punga, Anna Rostedt, et al.
Publicado: (2016)

The Practical Use of AbobotulinumtoxinA in Aesthetics
por: Kane, Michael A. C., et al.
Publicado: (2017)

New Uses of AbobotulinumtoxinA in Aesthetics
por: Schlessinger, Joel, et al.
Publicado: (2017)

Central Forehead Ischemic Skin Injury following Glabellar Botulinum: A Paradigm Microshift?
por: Hynes, Stephanie D., et al.
Publicado: (2023)

AbobotulinumtoxinA: A 25-Year History
por: Monheit, Gary D., et al.
Publicado: (2017)

Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study
por: Rappl, Thomas, et al.
Publicado: (2013)

Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport)
por: Dover, Jeffrey S.
Publicado: (2017)

IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study
por: Wu, Yan, et al.
Publicado: (2023)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy
por: Delgado, Mauricio R., et al.
Publicado: (2017)

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017)

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
por: Nestor, Mark, et al.
Publicado: (2017)

Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines
por: Joseph, John H, et al.
Publicado: (2022)

Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
por: Trosch, Richard M., et al.
Publicado: (2020)

Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia
por: Samotus, Olivia, et al.
Publicado: (2023)

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
por: Nomikos, Nikolaos, et al.
Publicado: (2023)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2016)

Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension
por: Gracies, Jean-Michel, et al.
Publicado: (2017)

Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review
por: Cohen, Joel L., et al.
Publicado: (2017)

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
por: Muthukumar, Madhusubramanian, et al.
Publicado: (2017)

Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
por: Fasano, Alfonso, et al.
Publicado: (2020)

Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis
por: Gracies, Jean-Michel, et al.
Publicado: (2021)

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
por: Abogunrin, Seye, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mg5nfeo77hctl9st95psuijpsr